Novir was born amid the pandemic.

In early 2020, COVID-19 was on the rampage across Europe, beginning to take hold in the United States, and soon to become a global pandemic. People were falling ill in alarming numbers. Too many were dying, and a problem was quickly becoming clear: a lack of testing. You can’t slow the spread of the coronavirus until you know where it is, and where it has been.

You need comprehensive testing to keep people safe, make informed decisions, and to eventually reopen, stay open, safely.

Alexander Kempe, an experienced, tenured, former GE Healthcare Executive turned investor and entrepreneur, felt this deeply, personally, and professionally. His family, friends and colleagues from his native Sweden were scared, and feeling the effects of the pandemic like millions of others.

Novir was launched on April 9, 2020, with a vision of making reliable and inexpensive, point of care COVID-19 screening tests available to anyone, anywhere with immediate results for quick action, displacing the current expensive lab tests fraught with lead time and capacity constraints. Partnerships with Swedish company Noviral and Milwaukee-based MPE-INC would spur the development and manufacturing of Novir’s own products.

Kempe sought to find the right talent to realize the vision and began to mobilize a team, together with local partners. He soon found foundational partners like Peter Klug — himself with more than 25 years of global leadership experience in the health care and manufacturing industries – and together they built a team of experts in health care, medical, operations and technology to drive early growth and build out of the company.

Thanks to this industry-leading team of professionals focused on fulfilling customer needs; Novir’s global network, with access to experience in pandemic response, public health and epidemiology; and depth in technology solutions, Novir has developed a myriad of preventive healthcare solutions including lead testing, vaccinations, biometrics, population health management analytics, drug testing and much more!